A detailed history of Envestnet Asset Management Inc transactions in Absci Corp stock. As of the latest transaction made, Envestnet Asset Management Inc holds 79,549 shares of ABSI stock, worth $462,975. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,549
Previous 94,025 15.4%
Holding current value
$462,975
Previous $359,000 42.06%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 12, 2025

SELL
$2.55 - $4.38 $36,913 - $63,404
-14,476 Reduced 15.4%
79,549 $208,000
Q3 2024

Nov 06, 2024

BUY
$2.97 - $4.49 $55,770 - $84,313
18,778 Added 24.96%
94,025 $359,000
Q2 2024

Aug 08, 2024

BUY
$2.92 - $6.58 $22,212 - $50,054
7,607 Added 11.25%
75,247 $231,000
Q1 2024

May 13, 2024

BUY
$3.41 - $5.74 $230,652 - $388,253
67,640 New
67,640 $384,000
Q3 2023

Nov 13, 2023

BUY
$1.28 - $2.41 $17,066 - $32,132
13,333 New
13,333 $17,000

Others Institutions Holding ABSI

About Absci Corp


  • Ticker ABSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 92,843,504
  • Market Cap $540M
  • Description
  • Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process....
More about ABSI
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.